Clinical trial
Amniotic Fluid Optical Density Determination Between 28 and 36 6/7 Weeks of Pregnancy and Its Relationship With the Diagnosis of Neonatal Respiratory Distress Syndrome.
NCT02332304 is registered in ClinicalTrials.gov with Saint Thomas Hospital, Panama as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amniotic Fluid Optical Density Determination Between 28 and 36 6/7 Weeks of Pregnancy and Its Relationship With the Diagnosis of Neonatal Respiratory Distress Syndrome.
- Lead sponsor
- Saint Thomas Hospital, Panama
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- December 31, 2014
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.